Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.


Updates from The Motley Fool

Latest updates on Bristol-Myers Squibb from Fool.com.  The Fool has written over 900 articles on Bristol-Myers Squibb.
2016's Worst Clinical Failures

It's been a depressing year for drugmakers, and clinical trial failures made 2016 particularly up...

3 Reasons Bristol-Myers Is a Buy

Image source: Bristol-Myers Squibb. Fresh off a data release announcement providing full details ...



Stock Performance

View Interactive BMY Charts
Sponsored by

Key Data Points

Primary metrics and data points about Bristol-Myers Squibb.
Current Price: $56.14
Prev Close: $56.28
Open: $56.51
Bid: $56.10
Ask: $56.11
Day's Range: $55.89 - $56.55
52wk Range: $49.03 - $77.12
Volume: 3,210,612
Avg Vol 8,414,602
Market Cap: $94B
P/E (ttm): 18.27
EPS (ttm): $3.08
Div & Yield: $1.52 (2.8%)

Company Rating

What our community thinks about Bristol-Myers Squibb.
CAPS Rating 4 out of 5
 
1750 Outperform
113 Underperform
CAPS All Stars
 
443 Outperform
15 Underperform

How do you think Bristol-Myers Squibb will perform against the market?



You pick for Bristol-Myers Squibb is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Giovanni Caforio, CEO

87% Approve

Based on 177 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Bristol-Myers Squibb.

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers